Jim Simons Aptorum Group LTD Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.95 - $1.67 $34,200 - $60,120	-36,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.22 - $2.28 $56,068 - $104,784	-45,958 Reduced 56.08%	36,000 $60,000
Q4 2021 Feb 11, 2022	BUY	$1.5 - $2.64 $100,587 - $177,033	67,058 Added 450.05%	81,958 $123,000
Q3 2021 Nov 12, 2021	SELL	$2.39 - $3.22 $73,612 - $99,176	-30,800 Reduced 67.4%	14,900 $38,000
Q2 2021 Aug 13, 2021	BUY	$2.37 - $3.43 $108,309 - $156,751	45,700 New	45,700 $146,000
Q2 2020 Aug 13, 2020	SELL	$2.81 - $4.7 $92,828 - $155,264	-33,035 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.06 - $16.0 $68,052 - $528,560	33,035 New	33,035 $121,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $9.02M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.